Short answer
Medtronic (MDT) filed its Q1 2025 10-Q quarterly report on Feb 25, 2025 for the quarter ended Jan 24, 2025. Quarterly revenue was $8.3B (up 2.5% year over year) with net income of $1.3B.
Q1 2025 key financials · XBRL
- Revenue
- $8.3B
- +2.5% YoY · −1.3% QoQ
- Net income
- $1.3B
- −2.1% YoY · +1.9% QoQ
- Operating margin
- 19.9%
- EPS (diluted)
- $1.00
- +1.0% YoY · +1.0% QoQ
Source: XBRL data from the Medtronic (MDT) Q1 2025 10-Q on SEC EDGAR. USD.
Medtronic Q1 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No newly added risk factors this quarter; risk section largely unchanged from the prior 10-K
- Pricing pressure risk updated with increased emphasis on decreasing selling prices impacting margins
- Regulatory risk includes delays in approvals and adverse regulatory actions affecting product launches
- Supply chain disruption risk highlighted as material operational concern due to potential interruptions
- Financial risk from liquidity shortfalls and currency exchange rate fluctuations persists affecting cash flow management
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Medtronic quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.